Age-associated changes in copper handling—including altered CP dynamics and impaired hepatic copper export—could therefore amplify COVID-19 severity by simultaneously weakening antiviral immunity and increasing vulnerability of metabolically active cells to copper-driven injury. The gene discussed is CP; the disease is COVID-19.